Gastrointestinal symptoms, including nausea, vomiting, and diarrhea, are more commonly observed with GLP-1RAs, particularly during dose escalation [28, 29]
Research is uncovering exciting potential benefits in other areas: Important note: These off-label or experimental uses are not yet FDA-approved
Currently, there are a lot of gray and black market options out there that have not been tested and thus lack quality and safety control
Genetic associations with insulin were obtained from MAGIC in 98,210 people [33]
Its primarily used for arthritis, joint pain, CCL tears, IVDD, post-surgical recovery, and GI issues like IBD or leaky gut
Oral and injectable GLP-1 medications like semaglutide are available in different forms and doses